Infant Presenting With Developmental Regression and Infantile Spasms Diagnosed as Zellweger Spectrum Disorder

Among the Zellweger spectrum disorders of peroxisomal biogenesis, Zellweger syndrome (ZS) is the most severe of identified disorders in this spectrum. Clinical features include facial dysmorphism, neuronal migration defects, failure to thrive, and hearing and visual impairment. Intracellular accumulation of very-long-chain fatty acid (VLCFA) damages developing organs (eg, liver, bone, kidneys, brain).It is diagnosed by estimating VLFCA and plasmalogen levels and genetic testing modalities. Mutations in the PEX group of genes are seen. The current case report highlights a case of ZS where the patient was thriving at 7 months with developmental delay, hypotonia, deafness, and seizures. The patient had chronic diarrhea and infantile spasms which are rarely described in peroxisomal biogenesis disorders. We report this child to highlight the diagnostic algorithmic approach of peroxisomal disorder.

[1]  C. Engelman,et al.  Carrier frequency estimation of Zellweger spectrum disorder using ExAC database and bioinformatics tools , 2019, Genetics in Medicine.

[2]  S. Naushad,et al.  Application of machine learning algorithms for the differential diagnosis of peroxisomal disorders , 2018, Journal of biochemistry.

[3]  M. Suijker,et al.  Coagulopathy in Zellweger spectrum disorders: a role for vitamin K , 2017, Journal of Inherited Metabolic Disease.

[4]  S. Ferdinandusse,et al.  Evaluation of C26:0-lysophosphatidylcholine and C26:0-carnitine as diagnostic markers for Zellweger spectrum disorders , 2017, Journal of Inherited Metabolic Disease.

[5]  Mohammad Afzal,et al.  Genetics of consanguinity and inbreeding in health and disease , 2017, Annals of human biology.

[6]  Michael F. Wangler,et al.  Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines. , 2016, Molecular genetics and metabolism.

[7]  S. Subramani,et al.  Distinct requirements for intra-ER sorting and budding of peroxisomal membrane proteins from the ER , 2016, The Journal of cell biology.

[8]  K. Abu-Amero,et al.  Neurometabolic Disorders-Related Early Childhood Epilepsy: A Single-Center Experience in Saudi Arabia. , 2015, Pediatrics and neonatology.

[9]  S. Ferdinandusse,et al.  Heimler Syndrome Is Caused by Hypomorphic Mutations in the Peroxisome-Biogenesis Genes PEX1 and PEX6 , 2015, American journal of human genetics.

[10]  K. Okumoto,et al.  Peroxisome biogenesis in mammalian cells , 2014, Front. Physiol..

[11]  N. Braverman,et al.  Peroxisome biogenesis disorders: Biological, clinical and pathophysiological perspectives. , 2013, Developmental disabilities research reviews.

[12]  G. Raymond,et al.  Child Neurology: Zellweger syndrome , 2013, Neurology.

[13]  A. Tylki-Szymańska,et al.  The Impact of a Ketogenic Diet and Liver Dysfunction on Serum Very Long-Chain Fatty Acids Levels , 2013, Lipids.

[14]  H. Waterham,et al.  Genetics and molecular basis of human peroxisome biogenesis disorders. , 2012, Biochimica et biophysica acta.

[15]  N. Shimozawa.  Molecular and clinical findings and diagnostic flowchart of peroxisomal diseases , 2011, Brain and Development.

[16]  A. Moser,et al.  Investigational Methods for Peroxisomal Disorders , 2008, Current protocols in human genetics.

[17]  H. Moser,et al.  Peroxisome biogenesis disorders. , 2006, Biochimica et biophysica acta.

[18]  Ronald J A Wanders,et al.  Biochemistry of mammalian peroxisomes revisited. , 2006, Annual review of biochemistry.

[19]  J. Grayer.  RECOGNITION OF ZELLWEGER SYNDROME IN INFANCY , 2005, Advances in neonatal care : official journal of the National Association of Neonatal Nurses.

[20]  H. Waterham,et al.  Identification of the molecular defect in patients with peroxisomal mosaicism using a novel method involving culturing of cells at 40°C: Implications for other inborn errors of metabolism , 2004, Human mutation.

[21]  B. Geisbrecht,et al.  Disruption of a PEX1-PEX6 interaction is the most common cause of the neurologic disorders Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[22]  H. Moser,et al.  Peroxisome assembly mutations in humans: Structural heterogeneity in Zellweger syndrome , 1992, Journal of cellular physiology.